Aequim Alternative Investments »

Halozyme Therapeutics shares owned by Aequim Alternative Investments

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Aequim Alternative Investments from 13F filings

Historical chart of Aequim Alternative Investments investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Aequim Alternative Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Aequim Alternative Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.3M 2.0M 1.15

More positions owned by Aequim Alternative Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Snowflake Note 10/0 (Principal)
Ford Mtr Note 3/1 (Principal)
Txnm Energy Note 5.750% 6/0 (Principal)
Evergy Note 4.500%12/1 (Principal)
Brightspring Health Svcs Unit 02/01/2027 (BTSGU)
Boeing Dep Conv Pfd A (BA.PA)
Airbnb Note 3/1 (Principal)
Hewlett Packard Enterprise C 7.625 Mand Conv (HPE.PC)
Rivian Automotive Note 3.625%10/1 (Principal)
Trip Com Group Note 0.750% 6/1 (Principal)
Etsy Note 0.125%10/0 (Principal)
Wec Energy Group Note 4.375% 6/0 (Principal)

View all positions for Aequim Alternative Investments

Top funds holding Halozyme Therapeutics

Steelhead Partners
Opti Capital Management
Linden Advisors
Millennium Management
MacKay Shields
DeepCurrents Investment Group
Tenor Capital Management
BlackRock
Lazard Asset Management
M&G
Calamos Advisors
Wellesley Investment Advisors
UBS O'Connor
Jpmorgan Chase & Co
State Street Corporation

View all funds holding Halozyme Therapeutics